Newsroom

NEW YORK--(BUSINESS WIRE)--Cloudaware, Inc., a provider of cloud asset management and observability solutions, today announced a partnership with Datadog, the observability and security platform for cloud applications, to bring Cloudaware LogSight to the Datadog Marketplace. The new integration helps joint customers answer a question most organizations can't: is every cloud service actually sending logs to Datadog? Cloud logs are notoriously fragmented – ELB logs route to S3, VPC Flow Logs to C...

纽约--(BUSINESS WIRE)--(美国商业资讯)-- 信任、透明化与问责制的领先审计就绪平台Workiva Inc. (NYSE: WK)今日宣布推出三款专用AI智能体以及基于组织的数据、指令和内容构建的持久智能层——Workiva Knowledge。 这些智能体将帮助高级解决方案层级的客户依托Workiva平台提供的控制力和可追溯性，加速实现报告与合规成果。这些功能的结合为企业团队提供了符合其组织所需速度和规模的受治理AI。 Workiva首席产品官Deepak Bharadwaj表示：“随着AI智能体承担越来越多的工作，财务、可持续发展、风险及合规团队正在从执行转向编排，而我们正在打造使这一转型成为可能的平台。在Workiva平台不断发展的过程中，我们始终秉持客户一直以来对我们的期望：提供准确性、透明度，以及贴合其工作实际与复杂性的解决方案。” 为不容有失的团队打造的智能体 报告与合规团队需要花费大量时间交叉核对数据，并根据标准和同业情况进行评估。这项工作至关重要，但在大规模执行时极其繁重。Workiva的专用AI智能体承担了这一重担，生成的输出结果可追溯、可辩护，且达...

DURHAM, N.C.--(BUSINESS WIRE)--FlexGen Power Systems, LLC. (“FlexGen”), un fornitore leader di sistemi di accumulo di energia a batteria e di software per la gestione energetica, oggi ha annunciato che la sua piattaforma di gestione dell'energia HybridOS è certificata ISO 9001:2015. Il testo originale del presente annuncio, redatto nella lingua di partenza, è la versione ufficiale che fa fede. Le traduzioni sono offerte unicamente per comodità del lettore e devono rinviare al testo in lingua or...

RUTHERFORD, N.J. & LA JOLLA, Calif.--(BUSINESS WIRE)--Lōkahi Therapeutics™ Inc., a wholly owned subsidiary of Glucotrack, Inc. (NASDAQ: GCTK), today announced progress in its LT-100 development strategy focused on evaluating whether a historical administration approach requiring up to 15 intradermal (ID) injections per treatment visit can be simplified to a single subcutaneous (SC) injection per visit. During a Type C meeting with the U.S. Food and Drug Administration in May 2026, the Company d...

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson1 (NYSE: JNJ) today announced strategic agreements and collaboration with Sail Biomedicines (Sail), a biotechnology company developing in vivo CAR-T therapies for immune-mediated diseases. Johnson & Johnson will collaborate with Sail to advance its lead immune-mediated disease program and broader platform technology, with incentives to expand the application of Sail's in vivo CAR-T platform across additional therapeutic targets over...

MAPLE GROVE, Minnesota--(BUSINESS WIRE)--VDyne Inc. (« VDyne »), société privée de dispositifs médicaux développant un système innovant de remplacement valvulaire tricuspide par cathétérisme (RVTC), a annoncé aujourd’hui le recrutement et le traitement du premier patient dans l’étude pivot TRIVITA US IDE du système TriNova™. Cette étude randomisée et contrôlée comparera directement le système TriNova™ au système RVTC Edwards EVOQUE™, déjà commercialisé. Le démarrage de l’essai TRIVITA (NCT07516...

NEW YORK--(BUSINESS WIRE)--Franklin BSP Realty Trust, Inc. (NYSE: FBRT) (“FBRT” or the “Company”) today announced financial results for the quarter ended June 30, 2026. During the second quarter, FBRT increased GAAP book value per share, generated distributable earnings that exceeded its quarterly dividend, continued repurchasing common stock and made further progress resolving legacy assets. Second Quarter 2026 Summary GAAP net income of $16.3 million or $0.12 per diluted common share Distribu...

NEW YORK--(BUSINESS WIRE)--Griffon Corporation (“Griffon” or the “Company”) (NYSE: GFF) today announced it will release the Company’s fiscal third quarter results on Wednesday, August 5, 2026, followed by a conference call at 8:30 AM ET. The call can be accessed by dialing 1-844-826-3035 (U.S. participants) or 1-412-317-5195 (International participants). Callers should ask to be connected to the Griffon Corporation teleconference or provide conference ID number 10210214. Participants are encour...

NORTH CHARLESTON, S.C.--(BUSINESS WIRE)--Ingevity raises full year Adjusted EBITDA outlook following a solid start to the year...

MAPLE GROVE, Minn.--(BUSINESS WIRE)--VDyne Inc. (“VDyne”), società privata produttrice di dispositivi medici che sviluppa un sistema innovativo di sostituzione della valvola mitrale transcatetere (TTVR), oggi ha annunciato che il primo paziente è stato registrato e trattato nello studio pivotale TRIVITA US IDE del sistema TriNova™. Lo studio randomizzato e controllato metterà a confronto diretto TriNova con il sistema disponibile in commercio Edwards EVOQUE™ TTVR. L'avvio dello studio clinico T...